Neuronetics, Inc. (STIM) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Neuronetics, Inc. on January 6, 2026, covering events occurring on December 30, 2025. The Company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol "STIM".
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on executive compensation arrangements.
Material Changes and Executive Compensation
On December 30, 2025, the Compensation Committee approved cash awards and Restricted Stock Unit (RSU) incentives for two senior executives:
- Steven E. Pfanstiel (EVP, CFO, and Treasurer): Approved a cash award of $240,000 and 170,212 RSUs.
- W. Andrew Macan (EVP, General Counsel, Chief Compliance Officer, and Corporate Secretary): Approved a cash award of $231,750 and 164,361 RSUs.
Vesting Conditions: The cash awards will be paid and the RSUs will vest on the earlier of June 30, 2027, or a termination of employment without cause.
Guidance, Outlook, and Risks
The filing text does not provide updated financial guidance, management commentary on future outlook, or specific risk factors beyond the standard disclosure of executive compensation terms.
Key Facts for Investor Verification
- Verify the total potential equity value of the 334,573 RSUs granted based on the current market price of STIM stock.
- Confirm the Company's current cash position to assess the impact of the $471,750 in immediate cash awards.
- Review the Company's most recent 10-K or 10-Q for baseline financial performance, as this 8-K contains no operational or financial results.
- Monitor the vesting schedule to understand the retention incentives for the CFO and General Counsel through mid-2027.